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1. Introduction 
Reversible protein phosphorylation is one of the most important and well explored post-
translational modifications. It is estimated that 30- 50% of the proteins are phosphorylated at 
some time point (Kalume, Molina, & Pandey, 2003). Phosphorylation is a major regulatory 
mechanism that controls many basic cellular processes. It may mediate a signal from the 
plasma membrane to the nucleus using a cascade of proteins, by which to regulate 
physiological and pathological processes such as cell growth, proliferation, differentiation 
and apoptosis (Blume-Jensen & Hunter, 2001; Hunter, 2000). Protein phosphorylation may 
result in alteration in protein- protein interactions, protein intracellular localization, and its 
activity (Blume-Jensen & Hunter, 2001; Kalume et al., 2003). Approximately 30% of drug 
discovery programs and R&D investment by the pharmaceutical industry target protein 
kinases. Knowledge of exactly when and where phosphorylation occurs and the 
consequences of this modification for the protein of interest can lead to an understanding of 
the detailed mechanism of the protein action, and ultimately to the discovery of new drug 
targets. 
Protein phosphorylation is a fast and reversible process. It is catalyzed by kinases by 
attaching phosphate groups onto specific amino acids. Opposed to phosphorylation, 
dephosphorylation removes the phosphate groups from proteins by phosphatases.  
Dephosphorylation plays important role in balancing the protein phosphorylation status in 
signaling proteins. About 2-3% of the human genome encodes 518 distinct protein kinases 
(Manning et al., 2002). Four types of phosphorylation have been described based on the 
phosphorylation sites: (a) O-phosphorylation (serine, threonine and tyrosine), (b) N-
phosphorylation (arginine, histidine and lysine), (c) S-phosphorylation (cysteine) and (d) 
acylphosphorylation (aspartic acid and glutamic acid) (Reinders & Sickmann, 2005). 
Currently, analytical methods have mainly been developed for O-phosphorylation, which is 
due to chemical stability of O-phosphorylation in acidic and in neutral milieu.  Therefore, O-
phosphorylation is the best studied among various types of phosphorylation (Reinders, 
2002). In eukaryotic cells, phosphorylation occurs primarily on serine (pSer), threonine 
(pThr), and tyrosine (pTyr) residues, that is estimated to be in the ratio of 1800:200:1/pSer: 
pThr: pTyr (Kersten et al, 2006).  
As aforementioned, phosphorylation is of importance for cell signaling and drug 
development. The lack of technologies to study all types of phosphorylation, differences in 
abundance and high dynamics make it difficult to have a comprehensive cover of all 
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phosphorylation events in cells. This chapter summarizes strategies that have been 
developed to characterize the phosphoproteome. These strategies include identification of 
phosphoproteins and phosphopeptides, localization of the exact phosphorylation sites and 
quantitation of phosphorylation. In addition, the applications of phosphoproteomics in life 
science are discussed.  
2. Phosphorylation 
2.1 Detection of phosphoproteins 
2.1.1 Radioactive labeling of proteins with 
32
P isotope  
Radioactive labeling of proteins with 32P or 33P is the oldest, but still one of the most 
sensitive approaches for detection of phosphorylation. Under the appropriate condition, the 
phosphoryl groups of 32P or 33P are enzymatic added to the proteins. The phosphorylated 
proteins are then detected by autoradiography. Therefore, radioactive labeling detects all 
types of phosphorylation, and is not specific to only one type of phosphorylation.  The 
proteins can be labeled with 32P/33P isotopes in vitro and in vivo. For in vitro labeling, [Ǆ-
32P/33P]-ATP is used. It is fast and convenient process, that requires (semi)purified kinase 
and substrate (Springer, 1991). A kinase phosphorylates its substrate in a defined mixture of 
the kinase, substrate, buffer, ions, ATP and [Ǆ 32P/33P]-ATP. However, since the enzymatic 
reaction takes place in vitro, the major disadvantage is that it may not reflect the kinase 
activity under physiological conditions.  This problem was overcome by introduction of the 
in vivo metabolic labeling (Wyttenbach & Tolkovsky, 2006).  [32P/33P]Orthophosphate is 
used in in vivo labeling as a source of the isotope. The radioactive orthophosphates are 
incorporated during metabolic processes by kinases in cells.  The significant advantage of in 
vivo labeling is that it provides a more accurate scenario of physiological enzymatic events, 
and reflects cellular responses as a consequence of treatments. The drawback of in vivo 
labeling also exists, e.g. it has been reported that in vivo labeling with doses of radioactivity 
may induce DNA fragmentation, DNA repair processes, subsequently may result in the cell 
cycle arrest and apoptosis. Another concern is that for in vivo labeling is usually used 
phosphate-free medium to culture cells. This medium may differ from the medium cells are 
cultured. Therefore, in vivo labeling experiments are often limited in time to 4- 8 hours. The 
third concern of radioactive labeling (in vitro and in vivo) is that only very small amount of 
radioactivity will be incorporated in proteins. This requires protocols for thorough removal 
of non-incorporated radioactivity from phosphorpoteins. The fourth concern of radioactive 
labeling is safety requirements. As the assays use radioactivity, corresponding safety rules 
have to be applied. Thus, it is very important to control quantity of the isotope and duration 
of labeling, take care of safety issues, and to minimize artificially-induced changes in 
phosphorylation.  
2.1.2 Phospho-specific antibodies 
In 1981, the first documented phospho-antibody was produced in rabbits immunized with 
benzonyl phosphonate conjugated to keyhole limpet hemocyanin (KLH) (Ignatoski, 2001). 
This antibody broadly recognized proteins containing phosphotyrosine. After that, there has 
been a rapid development in production of the phospho-antibodies. Nowadays, a large 
amount of phospho specific antibodies targeted to different amino acids (Ser, Thr, Tyr) at 
distinct sites in proteins have been produced, and widely used in the basic and clinic 
research (Ignatoski, 2001; Izaguirre, Aguirre, Ji, Aneskievich, & Haimovich, 1999). The 
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availability of phospho-specific antibodies has opened the door for the improvement of 
detection of phosphorylation. The advantages of phospho-antibodies consist in 4 issues. The 
first one is that the antibodies can be used not only with extracted proteins and peptides, but 
also for intact cells or tissues. The second issue is that the specificity and sensitivity may be 
very high if an antibody has really good quality, and antibody can detect the epitope down 
to femtomole range. The third issue is the antibodies can be used to enrich and purify 
phosphorylated proteins and peptides. The fourth issue is that there are many antibodies 
very useful for phosphotyrosine detection, with good specificity and minimal reactivity to 
either unphosphorylated tyrosine or phosphorylated serine/threonine residues. The major 
decisive factor for selection of antibodies is their specificity in detection of a 
phosphoprotein. Therefore the quality of antibodies becomes the key concern on their 
applications. 
2.1.3 Phosphoprotein staining 
Detection of phosphoproteins by staining proteins separated in the acrylamide gels with 
phosphor-specific dye has been widely used for almost forty years (Green et al., 1973). 
Historically, several phospho-staining protocols were used. The cationic carbocyanine dye 
“Stains-All” stains phosphoproteins, but also highly acidic proteins, DNA and RNA (Green 
et al., 1973). This dye is not commonly used due to its low sensitivity that is one order 
magnitude less sensitivity than Coomassie staining and several orders less than 32P 
radioactivity labeling.  An alternative method involves the alkaline hydrolysis of phosphate 
esters of serine or threonine, precipitation of the released inorganic phosphate with calcium, 
formation of an insoluble phosphomolybdate complex and then visualization of the 
complex with a dye such as malachite green, methyl green or rhodamine B (Debruyne, 
1983). The detection sensitivity of the staining method is still very poor, as a protein 
containing roughly 100 phosphoserine residues is detectable. Besides low sensitivity, 
phosphotyrosine is not to be detected as it cannot be hydrolyzed. Currently, ProQ Diamond 
has increasingly become the first choice of phosphoprotein dye (Steinberg et al., 2003). It is a 
fluorescent dye, and is suitable for the detection of phosphoserine-, phosphothreonine-, and 
phosphotyrosine-containing proteins directly in acrylamide gels. The sensitivity of ProQ 
Diamond staining has been improved significantly, and is down to 1- 16 ng. However, it is 
still considerably less sensitive than radioactive methods. The major advantages of ProQ 
Diamond are constituted of 1) it can be used in combination with a total protein stain, such 
as SYPRO Ruby protein gel stain, allowing protein phosphorylation levels and expression 
levels to be monitored in the same gel, 2) it is not dependent on kinase activity, 3) greater 
convenience and safety of handling, and 4) the stain also seems to be specific. However, in 
complex protein samples with thousands of protein species resolved by 2DE some 
nonphosphorylated, but rather abundant proteins may also be weakly stained (Stasyk et al., 
2005). 
2.1.4 Mass spectrometry (MS) 
Mass spectrometry is one of the most modern techniques for detection of phosphorylation. 
Introduction of MS has significantly advanced the research in protein phosphorylation 
(Peters et al., 2004). It may be applied not only for detection of phosphorylation, but also 
identification of phosphorylation sites. Detection of phosphorylation by MS has been based 
on mass spectrum generated by trypsin-digested peptides. The mass shift of m/z 79.9 or 
neutral loss m/z 80 or 98 compared to its theoretical peptide mass has normally been 
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considered as occurrence of phosphorylation. MS provides also a high speed and high 
sensitivity means for detection of phosphorylation.  However, there are several inherent 
difficulties for the analysis of phospho-proteins. Firstly, signals from phosphopeptides are 
generally weaker as compared to non-phosphorylated peptides, as they are negatively 
charged and poorly ionized by MS performed in the positive mode.  Secondly, it can be 
difficult to observe the signals from low-abundance phospho-proteins of interest in the 
high-background of abundant non-phosphorylated proteins. To overcome these drawbacks, 
enrichment of phophoproteins or phosphopeptides before MS is necessary to apply.  
2.2 Isolation and enrichment of phosphorylated proteins and peptides 
2.2.1 Immunoprecipitation 
Phosphospecific antibodies are an efficient tool for enrichment of phosphorylated proteins 
(Rush et al., 2005). Antibodies specific to phosphorylated residues are used to 
immunoprecipitate full-length proteins and phosphopeptides. The most notable advantage 
of this approach is the sensitivity provided by antibodies, as we discussed in 2.1.2. 
Nowadays, a variety of commercial phsopho-specifc antibodies with high quality are 
available, especially antibodies for phosphotyrosine. The lack of high quality 
phosphoserine/ threonine antibodies impedes the characterization of serine or threonine 
phosphorylations.  
2.2.2 Immobilized metal affinity chromatography (IMAC) 
IMAC (Andersson & Porath, 1986) is the most frequently used technique for 
phosphopeptide and phosphoprotein enrichment, although it was originally introduced for 
purification of His-tagged proteins. It employs metal chelating compounds which are 
covalently bound to a chromatographic support for the coordination of metal ions. 
Phosphorylated peptides or proteins are bound to the IMAC stationary phase by 
electrostatic interactions of its negatively charged phosphate group with positively charged 
metal ions bound to the column material via nitriloacetic acid (NTA), iminodiacetic acid 
(IDA), and Tris (carboxymethyl) ethylenediamine (TED) linkers. Immobilized metal ions 
such as Ni2+, Co2+, or Mn2+ were initially shown to bind strongly to proteins with a high 
density of histidines. However, immobilized metal ions of Fe3+, Ga3+, and Al3+ have been 
demonstrated to show better binding with phosphopeptides. On the basis of measurements 
of 32P or 33P-radioactivity in whole cell extracts and in phosphoprotein samples after 
enrichment, IMAC-based techniques have been reported to recover up to 70–90% of total 
phosphoproteins (Dubrovska & Souchelnytskyi, 2005). IMAC procedures have become very 
popular rapidly due to its good compatibility with subsequent separation and detection 
techniques such as LC-ESI-MS/MS and MALDI MS. One of the major drawbacks of IMAC-
based strategies is the nonspecific binding of peptides containing acidic amino acids, that is 
Glu and Asp, and the strong binding of multiply phosphorylated peptides. Nonspecific 
binding of acidic peptides can be diminished by esterification of carboxylic acids to methyl 
esters using HCl-saturated dried methanol (Ficarro et al., 2002). Reaction conditions have to 
be chosen carefully to avoid both incomplete esterification and side reactions because they 
increase sample complexity. Another disadvantage is that despite following a common 
binding-washing-eluting procedure, IMAC experimental conditions are very variable and 
care should be taken, as small variations in the experimental conditions (for example, pH, 
ionic strength, or organic composition of the solvents) could drastically affect the selectivity 
of the IMAC stationary phase.  
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2.2.3 Strong cation exchange chromatography (SCX) 
Strong cation exchange chromatography has been used in the enrichment of phosphorylated 
peptides (Peng et al., 2003). This procedure is based on the fact that under acidic conditions 
(pH 2.7) phosphorylated peptides are single positively charged and amenable to further 
separation from nonphosphorylated peptides that usually have a net charge of 2+ at low 
pH. One of the main advantages of this method is that complex peptide mixtures can be 
analyzed directly, since it can be connected directly to LC-MS/MS for identification or 
sequencing (Villen & Gygi, 2008). However, this strategy does not have high specificity and 
the fractions enriched in phosphopeptides also contain a high percentage of contaminants. 
Therefore, it’s very common to combine SCX with other enrichment methods, i.e IMAC and 
TiO2. 
2.2.4 Titanium dioxide (TiO2) 
A promising alternative to the use of IMAC for the enrichment of phosphorylated peptides 
was first described by Pinkse et al (Pinkse et al., 2004). The approach is based on the 
selective interaction of water-soluble phosphates with porous titanium dioxide 
microspheres via binding at the TiO2 surface. Phosphopeptides are trapped in a TiO2 
precolumn under acidic conditions and desorbed under alkaline conditions. An increased 
specificity for phosphopeptides has been reported. Another advantage of this approach is 
that it can be easily coupled with a LC-MS/MS workflow (Ishihama et al., 2007; 
Marcantonio et al., 2008). Nevertheless, TiO2-based columns may retain nonphosphorylated 
acidic peptides. Peptide loading in 2, 5-dihydroxybenzoic acid (DHB) has been described to 
efficiently reduce the binding of nonphosphorylated peptides to TiO2 while retaining high 
binding affinity for phosphorylated peptides. This improved TiO2 procedure was found to 
be more selective than IMAC.  
2.2.5 Chemical modification 
Biotin tagging by β-elimination and Michael addition 
A number of chemical modification strategies were developed in which the phosphate 
group has been replaced with a moiety that is chemically more stable than phosphate. One 
such method employs ǃ-elimination of the phosphate from phosphothreonine or 
phosphoserine and results in the formation of dehydroaminobutyric acid or 
dehydroalanine, respectively. This product can be detected directly using tandem MS 
(Thompson et al., 2003). Alternatively, Michael addition is used to add a reactive thiol to 
dehydroaminobutyric acid or dehydroalanine to allow attachment of an affinity tag. Biotin 
is a widely used affinity tag and it permits purification of the chemically modified 
(previously phosphorylated) peptides (Meyer et al., 1991). This chemical modification is not 
applicable to phosphotyrosine residues and suffers from side reactions in which 
nonphosphorylated serine can be tagged.  
2.3 Identification of phosphorylation sites 
2.3.1 Two-dimensional (2D) phosphopeptide mapping 
2D phosphopeptide mapping is a traditional biochemical method for identification of 
protein phosphorylation sites (Blaukat, 2004).  After metabolically labeling cells with 
radioactive phosphate, the protein of interest is isolated by immunoprecipitation, 
subsequently subject to enzymatic digestion. The digested phosphopeptide is visualized by 
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2D phosphopeptide mapping (electrophoresis and thin- layer chromatography). To 
determine a phosphorylation site, labeled spots from the 2D phosphopeptide map are 
excised, and a combination of phosphoamino acid analysis and Edman sequencing is 
performed by monitoring the loss of radioactivity in each cycle. It should be noted that 
phosphorylation sites identified by 2D mapping need further validation (Nagahara et al., 
1999). The most common way for confirmation is to mutate the phosphorylation sites and 
compare the phosphopeptide maps for the wild-type with those from mutant proteins. 
Although this method for phosphorylation identification is very useful, it still contains some 
limitations. It is time consuming process; care must be taken when label the cells with 
radioactivity; it only studies single protein, and can not apply to large scale identification of 
phosphorylation sites. Attempts were also made to combine 2D phosphopeptide mapping 
and MS analysis of recovered phosphopeptides by using 2D phosphopeptide mapping and 
HPLC purification before MS (Figure 1).  
 
 
Fig. 1. An overview of techniques for enrichment and analysis of phosphorylated proteins or 
peptides using MS-based detection methods. 
2.3.2 MS fragmentation 
2.3.2.1 Collision-induced dissociation (CID) 
PTMs on proteins often show greater susceptibility to cleavage by collision-induced 
fragmentation in the mass spectrometer than the peptide backbone. This characteristic may 
be used in different analytical strategies: 1) detection of the low mass ‘signature’ or ‘marker’ 
ions generated from the modification itself, 2) detection of the loss of the modification from 
the peptide precursor. Such targeted MS/MS analysis can enhance the specificity and 
sensitivity of phosphopeptide analysis, particularly for complex samples consisting of 
mixtures of phosphorylated and nonphosphorylated peptides. There are two most common 
precursor ion-scanning modes implemented on triple quadrupole mass spectrometers 
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(Figure 1). When phosphopeptides are fragmented by CID in the negative ion mode, a 
characteristic product ion (PO3) is generated giving rise to a peak at m/z 79 in the product 
spectrum (Collins et al., 2005). The detection of this marker ion has been used in various 
analytical setups. For example, a list of putative phosphopeptide ions can be generated by 
precursor ion scanning, a follow up analysis in positive ion mode is then performed to 
sequence these candidates by MS/MS using DDA (data-dependent acquisition) mode. 
Alternatively, detection of the precursor ion can be performed in positive ion mode, conduct 
MS/MS sequencing directly. Phosphotyrosine-containing peptides yield a characteristic 
immonium ion at m/z 216.043 from the loss of phosphotyrosine in the positive ion mode 
CID. Therefore, targeted monitoring of the precursor ion of 216.043 is useful for the 
detection of phosphotyrosine-containing peptides. This method was reported with good 
sensitivity, enabling the detection phosphotyrosine peptides from subpicomole amounts of 
gel-separated proteins (Steen et al., 2001). 
2.3.2.2 Electron capture dissociation (ECD) and Electron transfer dissociation (ETD) 
In tandem mass spectra of phosphopeptides generated by CID, limited or weak fragment 
ions spectra produce many false-negative as well as false-positive identifications especially 
for large, multiply charged and/or multiply phosphorylated peptides. Emerging alternative 
fragmentation techniques such as electron capture dissociation (ECD) and electron transfer 
dissociation (ETD) provide complementary sequence information for protein and peptide 
characterization, and are also applicable to the analysis of post-translational modifications 
(PTMs). These approaches induce more extensive cleavage along the peptide backbone and 
therefore provide excellent sequence tags, which retain labile PTMs (such as 
phosphorylation, glycosylation, acylation, ubiquitination and sumoylation) on backbone 
fragments. This feature enables direct and unambiguous assignment of the sites of 
modification. A further benefit is that these approaches are better suited for the analysis of 
large peptides, permitting the detection of multiple PTMs. 
In ECD, multiply protonated ions capture low energy electrons and upon the following 
charge neutralisation, the resulting radical cations dissociate along the peptide backbone to 
produce a series of c and z type fragment ions while retaining the labile PTM group 
(Zubarev et al., 1998). Since the electron capture process requires low energy electrons (<10 
eV) and long interaction times, the application of ECD was traditionally confined to 
instruments that employ static electromagnetic fields that avoid energizing or heating 
electrons, such as Fourier transform ion cyclotron resonance (FT-ICR) MS. Recently 
however, the addition of magnetic fields to ion traps have allowed for ECD in such 
electrodynamic trapping instruments (Baba et al., 2004) and the use of ECD in a digital ion 
trap mass spectrometer has also been reported (Ding & Brancia, 2006). 
Electron transfer dissociation (ETD) is similar to ECD in that it also induces relatively non-
selective cleavage of the N–Cǂ bond on a peptide's backbone producing c- and z-product 
ions, while maintaining phosphate groups and other potentially labile modifications (Syka 
et al., 2004). However, rather than involving the direct capture of an electron, ETD involves 
transfer of an electron to the multiply protonated precursor ion from a singly charged 
radical anion. The use of electron donors makes ETD amenable for use in quadrupole ion 
trap mass spectrometers which utilize rf fields for simultaneous storage and reaction of ions 
with positive and negative polarities. ETD fragmentation of phosphopeptides results in 
retention of phosphate groups in the sequence, allowing easier assignment of the exact site 
of modification. Moreover, these fragment ions are generated with good efficiency, making 
this a very promising approach for the analysis of phosphopeptides (Chi et al., 2007).  
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2.3.2.3 Photodissociation (PD) 
Furthermore, ions in the gas-phase may be excited and subsequently dissociated by 
absorption of the photons. Photodissociation uses a laser that is directed through a window 
to irradiate the interior of the analyser. The mechanism of fragmentation by 
photodissociation involves the absorption by one or more photons. As each photon is 
absorbed, the ion increases its internal energy. The energy accumulates and finally it is 
sufficient to provoke dissociation resulting in gas-phase fragmentation of the ion. Ion 
activation may be achieved using infrared lasers (Brodbelt & Wilson, 2009). Due to its 
relatively low energy (-0.1 eV/photon), the absorption of multiple IR photons (tens to 
hundreds) are required for ion dissociation. Like CID, IRMPD is a “slow heating” method 
and allows for intramolecular energy redistribution over all of the vibrational degrees of 
freedom prior to the next photon absorption event (McLuckey & Goeringer, 1997). As a 
result, ergodic dissociation of low-energy pathways predominates and the resulting spectra 
are generally comparable with those obtained by CID. Photodissociation in the UV range 
has targeted common chromophores such as the amide bonds of a peptide using 193 and 
157 nm light, as well as residue-specific chromophores such as aromatic amino acids using 
220, 266, and 280 nm light (Reilly, 2009). Photodissociation has some advantages over the 
aforementioned methods. It is relatively selective, as only ions absorb the wavelength of the 
light used are activated. These techniques are most often used with ion trapping mass 
spectrometers.7 
2.3.3 Site-specific microarrays 
Site-specific microarray use oriented peptide libraries to map target specificity of kinases. 
This approach is based on kinase consensus sequences and phosphorylation prediction 
algorithm. It is thought that many phosphorylation sites tend to occur in accessible and 
flexible regions in three dimensional protein structures, suggesting that phosphorylation of 
linear peptide sequences in vitro should be similar to phosphorylation of the intact protein 
for the majority of sites. Data derived from peptide array experiments is consistent with 
known kinase consensus sequences, and is therefore a useful tool for studying 
phosphorylation. Peptide microarrays consist of synthetic peptide sequences deposited on 
to glass slides or attached to a derivatised surface, usually in triplicate, with 
phosphorylation site substitutions as controls. The peptides could map the entire sequence 
of a protein or correspond to a dataset of peptides that for example may have been 
identified from an in vivo sample, by MS. The in vitro phosphorylation reaction is 
performed in the presence of radiolabelled ATP, the array exposed to film and the image 
captured. Once the set of peptides have been synthesized, a large number of these 
microarrays can be made to screen many kinases relatively quickly (Kemp et al., 1975; 
Zetterqvist et al., 1976). The limitation of site-specific microarray is that, in vitro data is not 
sufficient on its own to definitively prove that a kinase may phosphorylate a given site in 
vivo. It is reasonable to use this peptide array technology as a first approach to screen for 
possible substrates (Diks et al., 2004; MacBeath & Schreiber, 2000), but further validation is 
required. 
2.4 Quantification of protein phosphorylation  
The field of phosphorylation quantitation by proteomics has made important advances over 
the last few years (Nita-Lazar et al., 2008). In general, quantitative phosphoproteomics can 
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be performed as gel based and non-gel based (shotgun), e.g LC-MS/MS. Two-dimensional 
gel electrophoresis is a classical and powerful analytical method in proteomics that can 
separate complex mixtures of proteins based on charge (by isoelectric focusing) and 
apparent molecular mass (by sodium dodecyl sulfate polyacrylamide gel electrophoresis). In 
contrast to LC-MS/MS that analyzes digested peptides, 2DE delivers a map of intact 
proteins, which reflects changes in protein expression, isoforms or post-translational 
modifications. These changes can be confirmed by 1D or 2D Western blot analysis. Some 
forms of post-translational modification such as phosphorylation, glycosylation or limited 
proteolysis are easily located in 2DE gels as they appear as distinct spot trains along the 
horizontal and/or vertical axis. In 2DE, stoichiometry of phosphorylation can be readily 
determined by quantifying the spot intensity of each phosphorylated form. Furthermore, 
antibody-based approaches, using phosphorylation site-specific antibodies/Western blot 
analysis, ProQ Diamond staining and 32P radioactive labeling are most frequently used 
approaches for gel-based phosphoprotein quantification (Agrawal & Thelen, 2006; Gorg et 
al., 2004). 
Shotgun proteomics, where a peptide mixture from a sample is analyzed by LC-MS/MS 
without separating proteins on gels prior to the analysis, is a robust and high-throughput 
method that enables identification of thousands of proteins in a single analysis. There are 
many quantification methods in LC-MS/MS analysis, as summarized in the figure 2. Which 
method should be selected depends on the accuracy required, the sample source (from 
cultured cells or tissues) and the number of samples to be compared.  
The easiest way is a label-free method based on the spectral counts of identified peptides. 
An abundant peptide is represented by a large LC peak eluted for a long time and has more 
chance of being analyzed by MS/MS. Thus, the number of observed spectra assigned to a 
particular peptide is a semi-quantitative measure of the abundance of the peptide. Although 
the accuracy of quantification using spectral counts is not high, it is convenient for analyzing 
large quantitative differences between samples. Another label-free method measures the 
intensity of MS chromatograms. A number of methods have been developed to quantify 
peptides/proteins from peak heights in shotgun proteomics using an internal control. Using 
high-resolution MS instruments, a peptide ion can be analyzed accurately in the low parts 
per million mass unit range, and it facilitates the peptide signal mapping across a few or 
multiple LC-MS measurements, using their mass to charge and retention time dimension. 
Thus, this method depends on the mass resolution, the mass precision and the consistency 
of the retention time to match the same peptides among different LC-MS analyses. It is 
essential to use a high-resolution MS, as well as a sensitive and reproducible nano-LC where 
the retention time of a particular peptide in crude extract behaves exactly the same.  
Relative quantification based on differential stable isotope labeling is frequently used for 
quantitative phosphoproteomic analyses by MS. Although many techniques have been 
developed, only a few methods have been used in multiple laboratories. These include 
isotope-coded affinity tags, stable isotope labeling by amino acids in cell culture (SILAC) 
and the recently introduced chemical labeling by tandem mass tags, such as isobaric tag for 
relative and absolute quantitation (iTRAQ). SILAC and iTRAQ are currently the most 
frequently used techniques in quantitative MS-based phosphoproteomics. In SILAC, cell 
cultures to be compared are differentially labeled with amino acids containing stable 
isotopes, usually 13C6-Lys and/or 13C6-Arg, and normal amino acids. Lysates from 
differentially labeled cells are then mixed, digested with protease and analyzed by LC-
MS/MS. As a result, differentially labeled peptides (light and heavy) with the same amino  
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Fig. 2. Quantification methods for liquid chromatography-tandem mass spectrometry (LC-
MS/MS) analysis. There are two major methods for quantification: label-free, labeling with 
stable isotopes. The two main non-labeling methods are based on the intensity of MS 
chromatograms and the spectral counts of identified peptides. Labeling methods are classified 
into two major groups: metabolic labeling and in vitro labeling. The representative of the 
metabolic labeling is SILAC. In SILAC, two cell cultures to be compared are differentially 
labeled with heavy amino acids containing stable isotopes (heavy) and normal amino acids 
(light). Lysates from differentially labeled cells are mixed, digested with protease and analyzed 
by LC-MS/MS. Differentially labeled peptides having the same amino acid sequence are 
detected in MS spectrum, and the relative abundance of the peptides can be compared by 
calculating their ratio. The representative of the in vitro labeling is performed using isobaric 
amine-specific tandem mass tags, such as iTRAQ. The iTRAQ reagent consists of reporter 
regions with 1 Da difference (molecular weight: 114, 115, 116…) and balance regions that 
adjust the molecular weight of the labeled parent ions (molecular weight: 31, 30, 29…). Each 
tag generates a unique reporter ion in the MS/MS spectra, and the relative abundance of the 
peptides can be compared by calculating their ratio.  
acid sequence are detected in the MS spectrum, and the relative abundance of the peptides 
derived from different samples can be compared by calculating their ratio. Isobaric tagging 
for relative and absolute quantitation/tandem mass tags is a recently developed protein 
quantification method that uses isobaric amine-specific tandem mass tags and quantification 
in MS/MS instead of MS spectra. In MS spectra, the differentially labeled peptides possess 
the same mass by using the balance region in the tag and are represented in a combined 
single peak (Figure 2). However, each tag generates a unique reporter ion, and the 
intensities of the reporter ions in the MS/MS spectra are compared for protein 
quantification. iTRAQ can comparatively analyze four or eight different conditions in one 
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experiment. This chemical labeling method is suitable for the phosphoproteomic analysis of 
tissue and clinical samples.  
2.5 Application of phosphoproteomics 
2.5.1 MS based applications 
As described before, MS based phosphoprofiling can be performed at either gel or gel-free 
based level.  Gel based phosphoproteome profiling indicates that intact phosphoproteins 
were isolated and enriched from samples, and subsequently subject to 1DE or 2DE. To 
explore changes in protein phosphorylation in MCF-7 cells overexpressing Samd2/3 in 
response to TGFǃ1 stimulation, Stasyk et al (Stasyk et al., 2005) generated 2DE gels using 32P 
labeled proteins, 32 proteins were identified with high confidence. One of the identified 
targets, transcription factor-II-I (TFII-I), was found in three phosphoprotein spots of similar 
molecular mass, suggesting at least three sites of phosphorylation of TFII-I. 2D 
phosphopeptide mapping of TFII-I identified Ser371 and Ser743 as two phosphorylation 
sites. Mutation of Ser 371 and Ser743 led to the abrogation of TGFǃ1-dependent regulation 
of Cyclin D2, Cyclin D3, and E2F2 gene expression. Our lab previously developed a 
quantitative phosphoproteomics approach using phosphoprotein enrichment by Fe-IMAC 
followed by 2DE, which allows recovery of up to 90% of phosphoproteins, and can be 
applied to cultured cells and tissues (Dubrovska & Souchelnytskyi, 2005). We applied this 
approach to investigate the crosstalk of EGF and TGFǃ signaling pathway in MCF-7 cell, 
and identified 47 convergent components of these two pathways. Systemic analysis 
identified MEK1 and CK1 as the primary common components of EGF and TGFǃ signaling 
pathway in regulation of cell proliferation. Cell proliferation analysis showed that inhibition 
of MEK1 and CK1 can affect cell proliferation in the context of EGF and TGFǃ treatment. 
And our experimental data also suggested that cross-talk between EGF and TGFǃ may affect 
the responsiveness to Iressa in MCF-7 cell. Huber et al. performed two-dimensional 
differential gel electrophoresis (2D-DIGE) after purification of endosomes from EGF-treated 
mouse epithelial cells and identified 23 endosomal targets of EGF receptor signaling, such as 
R-Ras (Stasyk et al., 2007). Tang et al. performed 2D-DIGE analysis of phosphoprotein and 
plasma membrane fractions from brassinosteroid-treated Arabidopsis (Tang et al., 2008) and 
identified homologous protein kinases as key transducers of this steroid hormone signaling 
in plants (Tang et al., 2008). Thus, the combination of enrichment of phosphoproteins and 
2D is a powerful proteomics approach for unraveling protein kinase-mediated signaling 
networks. 
Gel-free (shotgun) proteomics, e.g LC-MS/MS analysis have been developed and 
successfully applied to quantify phosphopeptides from various cells and tissues. Ineffective 
erythropoiesis in human hematopoietic stem cells has been implicated in Hemoglobin 
E/beta-thalassemia. Ponnikorn et al. compared the phosphoprofiling of human 
hematopoietic cells between healthy donors and Hemoglobin E/beta-thalassemia patients 
(Ponnikorn et al., 2011). They enriched the phoshoproteins by IMAC, followed by LC-
MS/MS for identification, and found 229 differentially phosphorylated proteins. To 
investigate the mechanisms of resistance to Her2 tyrosine kinase inhibitor lapatinib, 
Arteaga’s group profiled the tyrosine phosphoproteome of sensitive and resistant cells using 
an immunoaffinityenrichment and mass spectrometry method (Rexer et al., 2011). Peptides 
containing phosphotyrosine were isolated directly from protease-digested cellular protein 
extracts with a phosphotyrosine-specific antibody and were identified by tandem mass 
spectrometry. They found increased phosphorylation of Src family kinases (SFKs) and 
www.intechopen.com
 
Integrative Proteomics 
 
226 
putative Src substrates in several resistant cell lines. Treatment of these resistant cells with 
Src kinase inhibitors partially blocked PI3K-Akt signaling and restored lapatinib sensitivity. 
Further, SFK mRNA expression was upregulated in primary HER2+ tumors treated with 
lapatinib. Finally, they observed that the combination of lapatinib and the Src inhibitor 
AZD0530 was more effective than lapatinib alone at inhibiting pAkt and growth of 
established HER2-positive BT-474 xenografts in athymic mice. Ståhl et al. profiled 
phosphoproteome of ephrin and Eph signaling circuit. They combined SCX 
chromatography and TiO2 for enrichment of phosphopeptides followed by nano-LC and 
MS analysis (Stahl et al., 2011), and identified 1083 unique phosphorylated proteins. Out of 
these, 150 proteins were found only when ephrin B3 is expressed, whereas 66 proteins were 
found exclusively in U-1810 cells with silenced ephrin B3. Cantrell’s group reported an 
unbiased analysis of the cytotoxic T lymphocyte (CTL) serine-threonine phosphoproteome 
by high-resolution mass spectrometry (Navarro et al., 2011). They used SILAC and IMAC 
based phosphopeptide enrichment, and identified approximately 2,000 phosphorylations in 
CTLs, of which approximately 450 were controlled by T cell antigen receptor (TCR) 
signaling. SILAC-based method also applied to study phosphorylation changes in EGF-
stimulated HeLa cells (Olsen et al., 2006). After enrichment of phosphopeptides with SCX 
and TiO2, temporal profiles of 6600 unique phosphorylation sites on 2244 proteins were 
determined, including many known members of the EGF receptor signaling pathway. More 
recently, the cell cycle profiles of 20,443 phosphorylation sites in 6027 proteins have been 
determined and the site-specific stoichiometry of more than 5000 sites has been achieved by 
combining the results from corresponding non-phosphorylated peptides (Olsen et al., 2011). 
Comparative studies have revealed that different proteomic strategies are complementary to 
each other. For example, different phosphopeptide enrichment methods show distinct and 
partially overlapping preferences in phosphopeptide recovery. Bodenmiller and colleagues 
compared three different phosphopeptide enrichment approaches, phosphoramidate 
chemistry (PAC), IMAC and TiO2. They observed that among repeat isolates for each 
method pattern, overlap was ranging from an average of 80% for PAC (average of 6,643 
features per run (FPR)), 76% for TiO2 (8,459 FPR), 74% for IMAC (9,312 FPR) (Bodenmiller et 
al., 2007). This suggested that no single method is sufficient for a comprehensive 
phosphoproteome analysis, and combination of different approaches for enrichment can 
improve the comprehensiveness of phosphoproteins. Furthermore, phosphoproteomic 
profiling of the ERK pathway using 2D-DIGE, label-free precursor ion scanning and SILAC 
identified surprisingly different subsets of ERK targets (Kosako & Nagano, 2011). Thus, a 
combination of various phosphoproteomic strategies, such as LC-MS/MS, 2DE and peptide 
(protein) microarrays, can increase the reliability and comprehensiveness of the data 
obtained. 
2.5.2 Arrays-based application 
Protein microarray technology offers the potential for profiling the proteome without 
employing separation techniques and evaluating protein biochemistry in a high-throughput 
and systematic manner.  Synder’s group have done large amount of work in protein 
microarray, including application in phosphoproteomics (Kafadar et al., 2003; Ptacek et al., 
2005; Zhu et al., 2000). In 2000 his group screened 119 of the 122 yeast kinases with 17 
different substrates (including the kinases themselves for monitoring autophosphorylation) 
on a prototype of protein microarray (Zhu et al., 2000). The substrates were immobilized 
onto nanowell protein chips and phosphorylation events were identified by adding 33P-Ǆ-
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ATP and a specific yeast kinase and exposing the chip to a phosphoimager. They discovered 
that more than 60% of the kinases autophosphorylated themselves, and 94% of the tested 
kinases had at least one substrate in vitro, with 32 of them specifically phosphorylating one 
or two substrates. Twenty-seven kinases were found to phosphorylate poly (Tyr-Glu), 
which quadrupled the number of identified tyrosine kinases (seven) reported at that time. 
Moreover, these tyrosine kinases preferentially contain 3 conserved lysines and one 
conserved methionine near the catalytic region, indicating their potential roles in substrate 
selection. The same method was later used to identify Hrr25p as a kinase for the zinc-finger 
transcription factor Crz1, which turned out to negatively regulate Crz1 activity and nuclear 
localization by phosphorylation in vivo (Kafadar et al., 2003). His group later expanded the 
study to search for the substrates of 87 different S. cerevisiae kinases in a large set of more 
than 4400 full-length, functional yeast proteins with a yeast protein microarray containing 
4400 yeast proteins (Ptacek et al., 2005). In this study they discovered about 4200 
phosphorylation events affecting 1325 proteins and generated the first version of the 
phosphorylation network in yeast. In contrast to previous protein arrays that immobilize the 
probe, Paweletz et al developed reverse phase protein array, which immobilizes the whole 
repertoire of patient proteins that represent the state of individual tissue cell populations 
undergoing disease transitions (Paweletz et al., 2001). A high degree of sensitivity, precision 
and linearity was achieved, making it possible to quantify the phosphorylated status of 
signal proteins in human tissue cell subpopulations. Using this novel protein microarray 
they  have analyzed the state of pro-survival checkpoint proteins at the transition stage from 
patient matched histologically normal prostate epithelium to prostate intraepithelial 
neoplasia (PIN) and then to invasive prostate cancer. Cancer progression was associated 
with increased phosphorylation of Akt (P<0.04), suppression of apoptosis pathways 
(P<0.03), as well as decreased phosphorylation of ERK (P<0.01). c-Src tyrosine kinase plays a 
critical role in signal transduction downstream of growth factor receptors, integrins and G 
protein-coupled receptors.  
Amanchy et al. employed peptide microarrays approach and identified tyrosine 
phosphorylation sites in c-Src substrates (Amanchy et al., 2008). They designed custom 
peptide microarrays containing all possible tyrosine-containing peptides and their mutant 
counterparts containing a Tyr → Phe substitution from the identified substrates. In all, 624 
WT or mutant (312 WT and 312 MUT) peptides from 14 proteins were spotted with each 
sequence being represented in triplicate, on to the glass slides. c-Src kinase assays were 
performed on the peptide microarrays and the arrays subsequently exposed to 
phosphorimager screen. From this analysis, 12 out of 14 proteins phosphorylation sites were 
identified. 
3. Challenges, limitations, future directions and potential 
The term 'phosphoproteomics' describes a subdiscipline of proteomics that is focused on 
deriving a comprehensive view of the extent and dynamics of protein phosphorylation. 
Phosphoproteomics greatly expands knowledge about the numbers and types of 
phosphoproteins, and promotes rapidly the analysis of entire phosphorylation-based 
signaling networks. The combination of quantitative methods and phosphoproteomics has 
generated powerful technologies for studying cellular signaling. However, there are still 
many challenges to the approach itself.  Firstly, further improvements of the 
comprehensiveness are necessary. Ideally one could identify every single phosphorylation, 
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independent of its concentration. However, currently most of the time people only look at 
most abundant ones. Lack of comprehensiveness impacts reproducibility. Data-dependent 
acquisition in MS is inherently irreproducible, so alternative ways of choosing ions for 
further fragmentation are needed. Additional complementary techniques are also needed, 
such as starting with proteases other than trypsin. Secondly, optimization of enrichment 
techniques for phosphopeptides and phosphoproteins also pose a significant challenge. As 
we discussed in 2.5.1, currently no single enrichment method can fully recovery of 
phosphoproteins and phosphopeptides. Combination of different enrichment methods will 
be an efficient way to this problem. Thirdly, the interpretation of quantitative 
phosphoproteomics studies is complicated because each differential phosphorylation event 
integrates both changes in protein expression and phosphorylation. Studies have been 
performed by parallel comparisons of protein expression and phosphorylation in S. 
cerevisiae, and it has been found that 25% of seemingly differential phosphopeptides now 
attributed to changes in protein expression (Wu et al., 2011). Hence, correct interpretation of 
comprehensive phosphorylation dynamics requires normalization by protein expression 
changes. In addition, despite the vast amount of quantitative phosphoproteomic data 
generated in recent studies, validation of these data has been quite limited. Furthermore, 
although large amount phosphorylation sites identified, most of these studies did not in-
depth investigate the biological functions of the phosphorylation sites in signaling 
transduction.  
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